Back to results
US 2023/0406937 A1Published application
Multispecific antibodies for targeting cd28 and pd-l1 and methods of use thereof
AssigneeJanux Therapeutics, Inc.
InventorsDavid CAMPBELL, Thomas R. DIRAIMONDO
Life of this patent
Estimating the term…
Abstract
Provided herein are antibodies that selectively bind to CD28 and PD-L1, pharmaceutical compositions thereof, as well as nucleic acids, and methods of use, and methods for making and discovering the same.
Claims77
A multispecific antibody comprising a cluster of differentiation 28 (CD28) binding domain and a programmed death-ligand 1 (PD-L1) binding domain.
Dependencies are inferred from the claim text.